OA12354A - Tartrate salts of thiazolidinedione derivative. - Google Patents

Tartrate salts of thiazolidinedione derivative. Download PDF

Info

Publication number
OA12354A
OA12354A OA1200300028A OA1200300028A OA12354A OA 12354 A OA12354 A OA 12354A OA 1200300028 A OA1200300028 A OA 1200300028A OA 1200300028 A OA1200300028 A OA 1200300028A OA 12354 A OA12354 A OA 12354A
Authority
OA
OAPI
Prior art keywords
tartrate
solvaté
accordance
compound according
methyl
Prior art date
Application number
OA1200300028A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA12354A publication Critical patent/OA12354A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
OA1200300028A 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative. OA12354A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
OA12354A true OA12354A (en) 2004-03-19

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300028A OA12354A (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative.

Country Status (37)

Country Link
US (1) US20040014790A1 (ru)
EP (1) EP1305311B1 (ru)
JP (1) JP2004505970A (ru)
KR (1) KR100755174B1 (ru)
CN (1) CN1455778A (ru)
AP (1) AP1785A (ru)
AT (1) ATE384059T1 (ru)
AU (1) AU2001276506A1 (ru)
BG (1) BG107604A (ru)
BR (1) BR0112982A (ru)
CA (1) CA2417827A1 (ru)
CY (1) CY1107252T1 (ru)
CZ (1) CZ2003313A3 (ru)
DE (1) DE60132461T2 (ru)
DK (1) DK1305311T3 (ru)
DZ (1) DZ3418A1 (ru)
EA (1) EA005408B1 (ru)
EC (1) ECSP034467A (ru)
ES (1) ES2296772T3 (ru)
GB (1) GB0019224D0 (ru)
HK (1) HK1057358A1 (ru)
HR (1) HRP20030068B1 (ru)
HU (1) HUP0300778A3 (ru)
IL (2) IL154275A0 (ru)
MA (1) MA25832A1 (ru)
MX (1) MXPA03001085A (ru)
NO (1) NO324596B1 (ru)
NZ (1) NZ524030A (ru)
OA (1) OA12354A (ru)
PL (1) PL360662A1 (ru)
PT (1) PT1305311E (ru)
SI (1) SI1305311T1 (ru)
SK (1) SK1462003A3 (ru)
UA (1) UA76720C2 (ru)
WO (1) WO2002012232A1 (ru)
YU (1) YU14603A (ru)
ZA (1) ZA200300961B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
CN108348292B (zh) 2015-10-27 2021-04-27 纳诺帕斯技术有限公司 具有机械性导引的微针装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
KR100755174B1 (ko) 2007-09-03
AU2001276506A1 (en) 2002-02-18
JP2004505970A (ja) 2004-02-26
HUP0300778A2 (hu) 2003-11-28
ZA200300961B (en) 2004-04-01
DE60132461T2 (de) 2008-12-24
NZ524030A (en) 2004-07-30
PL360662A1 (en) 2004-09-20
HUP0300778A3 (en) 2005-04-28
SK1462003A3 (en) 2004-06-08
EA005408B1 (ru) 2005-02-24
CY1107252T1 (el) 2012-11-21
WO2002012232A1 (en) 2002-02-14
PT1305311E (pt) 2008-04-07
CN1455778A (zh) 2003-11-12
CA2417827A1 (en) 2002-02-14
AP2003002736A0 (en) 2003-03-31
MA25832A1 (fr) 2003-07-01
YU14603A (sh) 2006-05-25
BR0112982A (pt) 2003-08-26
SI1305311T1 (sl) 2008-04-30
IL154275A (en) 2009-02-11
MXPA03001085A (es) 2003-05-27
EP1305311A1 (en) 2003-05-02
BG107604A (bg) 2003-09-30
US20040014790A1 (en) 2004-01-22
DK1305311T3 (da) 2008-05-19
ATE384059T1 (de) 2008-02-15
DE60132461D1 (de) 2008-03-06
EA200300230A1 (ru) 2003-06-26
AP1785A (en) 2007-10-04
HRP20030068A2 (en) 2005-02-28
KR20030022355A (ko) 2003-03-15
NO20030530D0 (no) 2003-02-03
EP1305311B1 (en) 2008-01-16
UA76720C2 (ru) 2006-09-15
CZ2003313A3 (cs) 2004-02-18
ECSP034467A (es) 2003-03-31
IL154275A0 (en) 2003-09-17
ES2296772T3 (es) 2008-05-01
NO324596B1 (no) 2007-11-26
DZ3418A1 (fr) 2002-02-14
GB0019224D0 (en) 2000-09-27
NO20030530L (no) 2003-02-03
HK1057358A1 (en) 2004-04-02
HRP20030068B1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
OA12354A (en) Tartrate salts of thiazolidinedione derivative.
US20040048899A1 (en) Tartrate salts of thiazollidnedione derivative
US20070185167A1 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
OA12355A (en) Tartrate salts of thiazolidinedione derivative.
WO2003050113A1 (en) Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione
OA12284A (en) Thiazolidinedione salt for treatment of diabetes mellitus.
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
US20040038968A1 (en) Thiazolidinedione derivative and its use as antidiabetic
AU2001292028A1 (en) Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
WO2003050112A1 (en) Toluenesulfonate hydrates of a thiazolidinedione derivative
NZ524029A (en) 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine2,4-dione, L(+) tartrate salt or a solvate thereof
WO2003053964A1 (en) 5- (4- (2- (n-methyl-n- (2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione nephtalenesulfonate salt and use against diabetes mellitus
WO2003050111A1 (en) Toluenesulfonate salts of a thiazolidinedione derivative
WO2003050114A1 (en) Sulfate salt of a thiazolidinedione derivative